PLM60

· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PLM60, covering 2017-05-24 to 2017-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas [Phase 2]